Authorised representative (AR)

Grifols (HK) Limited

Hong Kong MDACS·8 represented devices·3 applicants·Aug 05, 2015 – Aug 16, 2024

Total devices

Applicants

2015

First representation

2024

Most recent

AR overview

Bilingual authorised representative information and contact details

Authorised representative (EN): Grifols (HK) Limited
Phone: 21613100

Timeline

First representation: Aug 05, 2015
Most recent: Aug 16, 2024

Risk class distribution

Applicant partnerships

Top manufacturers represented by this AR

Hologic, Inc.

Grifols Diagnostic Solutions Inc.

Grifols Diagnostics Solutions Inc.

Recent registrations

Latest 15 MDACS listings represented by Grifols (HK) Limited

Device	Risk class	Applicant	Registered
IVD Test Reagent/Kits, Molecular Assay, Infection, Virus, Zika 体外诊断检测试剂/试剂盒、分子检测、感染、病毒、寨卡病毒	D	Grifols Diagnostic Solutions Inc. Grifols Diagnostic Solutions Inc.	Aug 16, 2024
IVD Test Reagent/Kits, Molecular Assay, Nucleic Acid Probe 体外诊断检测试剂/试剂盒、分子检测试剂盒、核酸探针	D	Grifols Diagnostic Solutions Inc. Grifols Diagnostic Solutions Inc.	Jun 14, 2023
IVD Test Reagent/Kits, Molecular Assay, Infection, Virus, West Nile Virus, RNA 体外诊断检测试剂/试剂盒、分子检测、感染、病毒、西尼罗河病毒、RNA	D	Grifols Diagnostic Solutions Inc. Grifols Diagnostic Solutions Inc.	Jun 14, 2023
IVD Test Reagent/Kits, Molecular Assay, Nucleic Acid Probe 体外诊断检测试剂/试剂盒、分子检测试剂盒、核酸探针	D	Grifols Diagnostics Solutions Inc. Grifols Diagnostics Solutions Inc.	Jun 14, 2023
IVD Test Reagent/Kits, Molecular Assay, Infection, Virus, West Nile Virus, RNA 体外诊断检测试剂/试剂盒、分子检测、感染、病毒、西尼罗河病毒、RNA	D	Hologic, Inc. Hologic	Oct 25, 2016
IVD Test Reagent/Kits, Molecular Assay, Nucleic Acid Probe 体外诊断检测试剂/试剂盒、分子检测试剂盒、核酸探针	D	Hologic, Inc. Hologic	Aug 23, 2016
IVD Test Reagent/Kits, Molecular Assay, Nucleic Acid Probe 体外诊断检测试剂/试剂盒、分子检测试剂盒、核酸探针	D	Hologic, Inc. Hologic	Sep 24, 2015
IVD Test Reagent/Kits, Molecular Assay, Nucleic Acid Processing, Replication 体外诊断检测试剂/试剂盒、分子检测、核酸处理、复制	D	Hologic, Inc. Hologic	Aug 05, 2015

About this profile

Grifols (HK) Limited serves as the authorised representative for 8 medical devices in Hong Kong's MDACS framework. Analyse applicant partnerships, risk class exposure, and recent regulatory activity to understand their market footprint.